500 patients with CVID -94% had infections -30% had autoimmunity -30% had chronic lung disease -10% had granulomatous disease -Dr. Mahta Mortezavi Need I convince you any further to consider CVID when evaluating your patients with rheumatic disease? #ACR19 @RheumNow

#ACR19 poll: Do you use Prednisone to manage symptoms of hand osteoarthritis? @RheumNow

Nice job @didemsayginmd ! Abstr#2144 single center rheumatic irAE experience - 50% required ICI interruption! 20% needed DMARDs @RheumNow #ACR19 #cleclinicrheum https://t.co/dGaIaKzYFS

@rheumnow #ACR19 ABS2594 prospective cohort study of 56 early cutaneous SSc pts found no association between ETAR &AT1R Abs positivity & vascular complications making ETAR &AT1R abs unlikely prognostic markers of Vasc complications #acrbest https://t.co/e9kNSFeBOx

Some immunodeficiencies present primarily with autoimmune or lymphoproliferative features…hence the need to consider immunodeficiency in patients with suspected rheumatic disease. Dr. Mahta Mortezavi #ACR19 @RheumNow

@DBrandmanMD speaking at #ACR19 on NAFLD: HOW MUCH WEIGHT LOSS to do you need to improve/reverse stages of #FattyLiver? >3% for steatosis >5% for NASH improvement >7% for NASH resolution >10% for cirrhosis reversal (only 10% of pts get there) @RheumNow @ACRheum

As recommended by @doctorswade's research, Dr. Mahta Mortezavi recommends checking baseline immunoglobulins prior to rituximab use. #ACR19 @RheumNow https://t.co/EMapSb0tTW

@RheumNow 5T063 Immunodeficiency for the Rheumatologist: immune defects and corresponding clincial features https://t.co/iUvjP6hNdY

Gut microbiome-altering drugs like steroids, PPIs and antibiotics had negative effect on tumor response when given prior to checkpoint inhibitor therapy abstr#1811 @RheumNow @cappelliMD @LCalabreseDO #acr19 #cleclinicrheum

Dr. Mease discusses the ACR/NPF recommendations for treatment naive PsA pts. This slide details starting with TNFi for patients. #ACRbest #ACR19 @RheumNow https://t.co/0GZ2RFPWjW

Romo increased BMD across eGFR subgroups vs Pbo. Reduction in new vertebral fractures not affected by eGFR. https://t.co/HMkREcwoQj #ACR19 @RheumNow plenary#2730 #ACRbest https://t.co/9ojwhmmZxx

• Efficacy and Safety of Romosozumab vs Placebo Among Patients with Mild-to-Moder…

Abstr# 2160: Myopenia is associated with risk of rotator cuff tearing in the elderly. A great reminder to encourage exercise and building muscle mass to our patients. #ACR19 @RheumNow https://t.co/w5WrL6YcD7

#ACR19 Poll: When treating PMR, how do you recognize when patients are having a relapse or flare while tapering steroids? @RheumNow

Risk of progression of MGUS to myeloma is 1%/yr #ACR19 @rheumnow 5T064 https://t.co/T0K0cNlW04

@rheumnow #ACR19 ABS2353 Real-life observ cohort study demonstrates ACPA testing well adopted by US rheum (77.6% tested at Dx) but does not influence treatment choice (Rx w/bDMARD had similar distribution regardless of ACPA status) https://t.co/2V8VqHATJd